drugset / Trial / NCT01698814
A Six-Week Safety Study of an Investigational Ophthalmic Solution
RandomizedParallel-groupDouble-blind
Summary
The purpose of this study was to evaluate the ocular safety of an investigational ophthalmic solution in subjects 2 years of age and older with asymptomatic eyes when administered once daily in both eyes for up to 6 weeks.
Timeline
- Start
- 2012-10
- Primary completion
- 2013-01
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olopatadine | Other / unclassified | — | Other |